12/23/2014 - 10:31am

Teva Pharmaceutical today announced that the Food and Drug Administration has approved Granix (tbo-filgrastim) Injection for self-administration by patients and caregivers. With the approval of this additional administration option, physicians will soon have the flexibility to prescribe Granix for either in-office or at home use.

12/22/2014 - 3:16pm

The Food and Drug Administration has granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs.

12/22/2014 - 11:42am

The Food and Drug Administration granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.

12/19/2014 - 2:41pm

M.D. Science Lab, manufacturers of Swiss Navy Premium Lubricants, on Thursday unveiled all-new packaging for their brand for mass-market storefronts.

12/19/2014 - 7:14am
Rinovum Women’s Health, a privately held, U.S.-based women’s health company, announced Friday that it has secured $3 million in a series C financing from its existing investor base.
12/18/2014 - 10:23am

The CVS Health Research Institute released a first look at the comparative utilization of two new hepatitis C treatments in the weeks following their respective launches.

12/17/2014 - 2:05pm

PL Developments on Wednesday announced that it has added menopause relief supplement, EstroG-100, to its private-label portfolio.

12/17/2014 - 11:36am

Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.

12/16/2014 - 3:27pm

An interest in proactive wellness and proper nutrition is fueling demand for functional foods, Packaged Facts noted Tuesday in a new report.